This Stocks offers a 4% Yield and 13% Upside
AbbVie (ABBV) is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie is worth a look for the growth and income investors as it has a 4.2% dividend yield and a price target with 13% upside potential. AbbVie’s most important product …